EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 263 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58 | -100.0% | 16,933 | +169.6% | 0.01% | -78.6% |
| Q3 2021 | $314,000 | +31.9% | 6,281 | +145.6% | 0.03% | +64.7% |
| Q1 2021 | $238,000 | 0.0% | 2,557 | -45.8% | 0.02% | +30.8% |
| Q1 2019 | $238,000 | +5.8% | 4,714 | +10.1% | 0.01% | +8.3% |
| Q1 2018 | $225,000 | -47.1% | 4,280 | -53.2% | 0.01% | -47.8% |
| Q4 2017 | $425,000 | – | 9,149 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |